The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.
Overview of Market Growth
- The chimeric antigen receptor T (CAR-T) cells market has experienced exponential growth.
- Market size increased from $2.76 billion in 2023 to $3.89 billion in 2024, at a CAGR of 40.9%.
- Forecasted growth to $14.35 billion in 2028, with a CAGR of 38.5%.
Drivers of Growth
- Breakthrough FDA approvals and successful clinical trials.
- Advances in gene editing techniques.
- Growing investment from pharmaceutical companies.
- Rising cancer incidence globally.
Rising Cancer Occurrence Drives Growth
- Cancer’s prevalence is a key driver for the CAR-T cells market.
- CAR-T cells used in treating various cancers including hematological malignancies and solid tumors.
- Global cancer cases expected to reach 1.9 million in 2021, with projected increases by 2040.
- Market players include Novartis International AG, Pfizer Inc., Kite Pharma, among others.
Read More On The Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2024 – https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report
Innovative Product Developments
- Product innovation is a significant trend.
- Companies focus on creating novel CAR-T cell-based treatments.
- Novartis AG launched the T-Charge CAR-T platform in December 2021.
- Major players driving innovation in the market.
Laurus Labs’ Strategic Acquisition
- Laurus Labs acquired a minority stake in Immunoadoptive Cell Therapy in November 2021.
- Strengthening biologics business and gaining access to emerging research areas.
- Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.
Market Segmentation
- By Target Antigen: CD19, CD22, Other Antigens.
- By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Others.
- By End User: Hospitals, Cancer Research Centres, Clinics.
Regional Insights
- North America led the CAR-T cells market in 2023.
Future Outlook
- Forecasted market growth attributed to regulatory streamlining and market expansion in emerging economies.
- Major trends include off-the-shelf CAR-T therapies and combination therapies.
- Technological advancements and focus on long-term safety and efficacy driving market evolution.
Conclusion
- The CAR-T cells market is witnessing remarkable growth, driven by factors such as rising cancer incidence and technological advancements.
- Innovations in product development and strategic acquisitions are shaping the market landscape.
- With continued research and development, the CAR-T cells market is poised for significant expansion in the coming years.
Request for A Sample Of The Global Chimeric Antigen Receptor T (CAR-T) Cells Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8124&type=smp